Ad
related to: Acute Myeloid Leukemia
Leukemia: Why do Black adults have worse health outcomes?
Medical News Today· 3 hours agoNew research examines racial disparities in a particularly aggressive form of blood cancer: acute ...
Decitabine may improve CAR-T efficacy in refractory/relapsed acute leukemia patients carrying TP53...
Nature· 1 day agoTP53 is a tumor suppressor gene and its inactivation promotes tumor growth and resistance to chemotherapy. Acute leukemia (AL) patients with TP53 alterations ...
FDA Places Clinical Hold on Sickle Cell Gene Therapy
Medscape· 1 day agoThe FDA placed a clinical hold yesterday on two gene therapy trials for sickle cell disease (SCD) after one participant developed acute myeloid
Is There Any Hope for bluebird bio Stock? | The Motley Fool
The Motley Fool· 1 day agoThe share price of bluebird bio (NASDAQ:BLUE) is down a staggering 70% over the past year. The...
bluebird bio: Positive Resolution Of Clinical Hold Could Drive Asymmetrical Upside
TipRanks via Yahoo Finance· 2 days agoThe challenge facing BLUE is how to resolve the issues it encountered with one of its first patients...
Thief steals Port of Entry officer's SUV following stem cell treatment in Aurora
KMGH 7 Denver· 6 days agoPort of Entry officer is issuing her own personal "Be On the Look Out" for a red Dodge Durango,...
Pleasant Valley teen raises funds for pediatric cancer research | Times News Online
Times News· 2 days agoHalloween was Schyler Herman’s favorite holiday. Moore, a senior and class president from Pleasant...
Kura Oncology, Inc. (KURA) Q4 2020 Earnings Call Transcript | The Motley Fool
The Motley Fool· 13 hours agoLadies and gentlemen, thank you for standing by and welcome to the Kura Oncology Fourth Quarter and Full Year 2020 Earnings Conference Call. Joining me on the call are Dr. Troy Wilson, our President ...
Researchers Halt Trials of Promising Sickle Cell Treatment
New York Times· 3 days agoTwo patients in a gene therapy study developed cancer years after treatment. Just when it seemed...
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
citybizlist Charlotte/Raleigh· 9 hours agoChimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today reported financial results for the ...
